All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-19566788

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	19566788	A194T	RT	P	Hepatitis B, Chronic	G C L	View
2	19566788	I233V	RT	P	Hepatitis B, Chronic	G C L	View
3	19566788	N236T	RT	P	Hepatitis B, Chronic	G C L	View
4	19566788	Q215S	RT	P	Hepatitis B, Chronic	G C L	View
5	19566788	V214A	RT	P	Hepatitis B, Chronic	G C L	View
6	19566788	C137L	RT	P	Hepatitis B, Chronic	G C L	View
7	19566788	G145R	RT	P	Hepatitis B, Chronic	G C L	View
8	19566788	I233L	RT	P	Hepatitis B, Chronic	G C L	View
9	19566788	I233S	RT	P	Hepatitis B, Chronic	G C L	View
10	19566788	I233T	RT	P	Hepatitis B, Chronic	G C L	View
11	19566788	M204K	RT	P	Hepatitis B, Chronic	G C L	View
12	19566788	M204R	RT	P	Hepatitis B, Chronic	G C L	View
13	19566788	M204T	RT	P	Hepatitis B, Chronic	G C L	View
14	19566788	V214E	RT	P	Hepatitis B, Chronic	G C L	View
15	19566788	V214T	RT	P	Hepatitis B, Chronic	G C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.